Merus

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Merus and other ETFs, options, and stocks.

About MRUS

Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors.

CEO

Sven Ante Lundberg

CEOSven Ante Lundberg

Employees

260

Employees260

Headquarters

Utrecht, Utrecht

HeadquartersUtrecht, Utrecht

Founded

2003

Founded2003

Employees

260

Employees260

MRUS Key Statistics

Market cap

4.13B

Market cap4.13B

Price-Earnings ratio

-13.44

Price-Earnings ratio-13.44

Dividend yield

—

Dividend yield—

Average volume

1.81M

Average volume1.81M

High today

$56.22

High today$56.22

Low today

$54.53

Low today$54.53

Open price

$54.93

Open price$54.93

Volume

1.24M

Volume1.24M

52 Week high

$62.98

52 Week high$62.98

52 Week low

$33.19

52 Week low$33.19

Analyst ratings

100%

of 18 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own MRUS. This list is generated using Robinhood data, and it’s not a recommendation.

Taiwan Semiconductor Manu…

Merus

Why Robinhood?

Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. Show more

MRUS Key Statistics

Analyst ratings

100%

People also own

Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors.